Acalabrutinib 100 mg Comp. revestido

ID 10615168 · Portal BASE
Price
Base Price
€4,826 .00
Effective Price
€4,826 .00 0.0%
Contract Details
Contract Type
Aquisição de bens móveis
Procedure
Ajuste Direto Regime Geral
CPV Code
33000000
Location
Portugal, Porto, Porto
Bidder Count
—
Winner
ASTRAZENECA - PRODUTOS FARMACÊUTICOS LDA
NIF 502942240
Company
Dates
Publication
18 Mar 2024
Celebration
26 Jan 2024
Contracting Entity
Instituto Português de Oncologia do Porto Francisco Gentil, E. P. E.
NIF 506362299
Public body
Data Source
Portal BASE
Api · synced 2026-04-17
Risk Flags
Score 75 · HIGH RISK
A2 · Late Publication
A2_PUBLICATION_AFTER_CELEBRATION
HIGH
Publication Date
18 Mar 2024
Signing Date
26 Jan 2024
Days Late
52
Rule
A2/A3 late publication: 52 days after signing (threshold: 10)
Detected 2026-03-06
A5 · Threshold Splitting
A5_THRESHOLD_SPLITTING
MEDIUM
Base price
4826.0
Threshold
5000.0
Rule
A5 threshold splitting: price within 5% below 5000.0
Detected 2026-03-06